| PERIOD ENDING | 30-Aug-09 | 31-May-09 | 1-Mar-09 | 30-Nov-08 | | Total Revenue | 42,518 | 36,697 | 35,497 | 49,166 | | Cost of Revenue | 31,570 | 27,489 | 27,385 | 39,380 | | | Gross Profit | 10,948 | 9,208 | 8,112 | 9,786 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,203 | 5,917 | 6,091 | 6,211 | | Non Recurring |
-
|
-
| 5,687 | 570 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,745 | 3,291 | (3,666) | 3,005 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 205 | 688 | 1,633 | 1,651 | | Earnings Before Interest And Taxes | 5,950 | 3,979 | (2,033) | 4,656 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 5,950 | 3,979 | (2,033) | 4,656 | | Income Tax Expense | 1,195 | 905 | (5,119) | 1,722 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,755 | 3,074 | 3,086 | 2,934 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 16,486 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,755 | 3,074 | 19,572 | 2,934 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,755 | $3,074 | $19,572 | $2,934 |
|
0.11% Nasdaq 0.00%
Income Statement
